The Uromigos

Health EN ↓ 485 episodes

Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Be sure to visit the podcast's website and support the creator: www.uromigos.org

Author

The Uromigos

Episodes

Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective 16.03.2020 27:09

Dena Battle (President, KCCure) asks key patient-focused questions about kidney cancer management during the COVID-19 pandemic. 

Episode 9: COVID-19 and Cancer: An International Perspective 16.03.2020 21:58

Five members of the groups from Europe and North America discuss the current situation for cancer patients. 

Episode 8: COVID-19 and Cancer Patients 13.03.2020 21:54

Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 

Episode 7: The First Uromigos Prostate Cancer Podcast 27.02.2020 25:32

Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer. 

Episode 6: Urothelial Cancer Highlights from ASCO GU 2020 26.02.2020 20:08

In this episode, Professor Tom Powles and Dr. Brian Rini talk to Dr. Kala Sridhar about key developments in urothelial cancer presented at ASCO GU 2020. 

Episode 5: Renal Highlights from ASCO GU 2020 24.02.2020 10:14

Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco. 

Episode 4: Treatment Choices in Front Line Advanced Renal Cancer 11.02.2020 26:39

Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options

Episode 1: Introduction to Uromigos Podcasts 11.02.2020 3:20

Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them

Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer 11.02.2020 30:18

Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.

Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer 11.02.2020 33:02

Guests Dr. Arjun Balar and Professor Seth Lerner give an overview of the recent FDA approval of pembrolizumab in this indication to Professor Tom Powles and Dr. Brian Rini.